BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Income Statement
NASDAQ:BIOX - Nasdaq - KYG1117K1141 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 383.29M | 464.83M | 415.10M | 328.40M | 206.70M | |||
| Minority Interest Expense | 204.20K | -3.01M | -1.39M | -3.30M | -3.00M | |||
| Cost Of Goods | 231.09M | 278.22M | 235.46M | 208.40M | 118.60M | |||
| Gross Profit | 152.65M | 186.61M | 179.64M | 120.00M | 88.10M | |||
| Operating Expenses | 130.55M | 143.40M | 127.26M | 87.60M | 53.50M | |||
| Research and Development | 10.41M | 10.64M | 9.89M | 4.10M | 4.00M | |||
| Selling, General, and Administrative Expenses | 110.18M | 113.51M | 101.87M | 72.80M | 44.40M | |||
| Operating Income | 21.83M | 43.20M | 52.37M | 32.40M | 34.60M | |||
| Interest Income/Expense | -31.23M | -25.21M | -22.59M | -16.80M | -20.20M | |||
| Other Income/Expense | -10.61M | -7.91M | -11.29M | -7.90M | -6.60M | |||
| Non Recurring Items | 1.25M | -45.80K | 610.60K | 6.40M | 2.80M | |||
| Income Before Taxes | -18.77M | 10.04M | 19.11M | 14.10M | 10.50M | |||
| Income Tax | -9.50M | 3.78M | -1.07M | 18.00M | 14.40M | |||
| Net Income | -9.06M | 3.24M | 18.78M | -7.20M | -6.90M | |||
| EBITDA | 45.71M | 64.50M | 71.77M | 41.59M | 40.87M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.14 | 0.05 | 0.30 | -0.17 | -0.18 | |||
| Non GAAP EPS | -0.13 | 0.06 | 0.25 | -0.14 | -0.18 | |||
| Statistics | ||||||||
| Gross Profit Margin | 39.83% | 40.15% | 43.28% | 36.54% | 42.62% | |||
| Profit Margin | -2.36% | 0.70% | 4.52% | -2.19% | -3.34% | |||
| Operating Profit Margin | 5.69% | 9.29% | 12.62% | 9.87% | 16.74% | |||
All data in USD